Facebook Linkedin RSS Twitter Youtube
Home 2024

Sanofi

Top 10 Best Selling Drugs
A-Lists

Top 10 Best Selling Drugs

StockWatch: Insmed Shares Leap 150%, as Analysts See Next Blockbuster
Drug Discovery

StockWatch: Insmed Shares Leap 150%, as Analysts See Next Blockbuster

Sanofi Invests over €1 Billion to Create New Bioproduction Capacity in France
Bioprocessing

Sanofi Invests over €1 Billion to Create New Bioproduction Capacity in France

Sartorius Collaborates with Sanofi on Downstream Process Intensification
Bioprocessing

Sartorius Collaborates with Sanofi on Downstream Process Intensification

StockWatch: MacroGenics Shares Crater after Trial Deaths
Drug Discovery

StockWatch: MacroGenics Shares Crater after Trial Deaths

Vaccines in Development
Infectious Diseases

Vaccines in Development

With $86M Oversubscribed Public Offering, Absci Eyes 2025 IND for Lead Candidate
Artificial Intelligence

With $86M Oversubscribed Public Offering, Absci Eyes 2025 IND for Lead Candidate

Going Small: Kymera’s Juliet Williams Touts Degrader Advantage in SLAS 2024 Keynote
Cancer

Going Small: Kymera’s Juliet Williams Touts Degrader Advantage in SLAS 2024 Keynote

Dupixent Redux? Synthekine, Sanofi Partner on Cytokine Therapies
Cancer

Dupixent Redux? Synthekine, Sanofi Partner on Cytokine Therapies

Sanofi to Acquire Inhibrx for Up to $2.2B, with AATD Candidate in Mind
Drug Discovery

Sanofi to Acquire Inhibrx for Up to $2.2B, with AATD Candidate in Mind

123...33Page 1 of 33
Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.